NUMUNAVI Trademark

Trademark Overview

On Tuesday, August 17, 2021, a trademark application was filed for NUMUNAVI with the United States Patent and Trademark Office. The USPTO has given the NUMUNAVI trademark a serial number of 90886347. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 19, 2024. This trademark is owned by Merck Sharp & Dohme Corp.. The NUMUNAVI trademark is filed in the Pharmaceutical Products category with the following description:

Human vaccine preparations
numunavi

General Information

Serial Number90886347
Word MarkNUMUNAVI
Filing DateTuesday, August 17, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements

Goods and ServicesHuman vaccine preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMERCK SHARP & DOHME LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065
Party NameMerck Sharp & Dohme Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Friday, August 20, 2021NEW APPLICATION ENTERED
Wednesday, April 13, 2022ASSIGNED TO EXAMINER
Monday, April 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 29, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 10, 2023SOU EXTENSION 1 FILED
Tuesday, January 10, 2023SOU EXTENSION 1 GRANTED
Thursday, January 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, July 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 4, 2024SOU EXTENSION 3 FILED
Thursday, January 4, 2024SOU EXTENSION 3 GRANTED
Saturday, January 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2023SOU EXTENSION 2 FILED
Monday, July 17, 2023SOU EXTENSION 2 GRANTED
Tuesday, September 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 26, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, September 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 6, 2023ASSIGNED TO EXAMINER
Friday, March 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 19, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, August 19, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

numunavi preparations vaccine human